Polycystic ovarian disease (PCOD)—pregnancy rate and outcome in in vitro fertilization
暂无分享,去创建一个
I. Ben-Shlomo | J. Dor | S. Mashiach | D. Levran | D. Bider
[1] J. Dor,et al. The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study. , 1992, Fertility and sterility.
[2] T. Tanbo,et al. In-vitro fertilization in infertile women with the polycystic ovarian syndrome. , 1991, Human reproduction.
[3] T. Tanbo,et al. Stimulation with human menopausal gonadotropin versus follicle‐stimulating hormone after pituitary suppression in polycystic ovarian syndrome , 1991, Fertility and sterility.
[4] E. Rudak,et al. The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. , 1990, Human reproduction.
[5] R. Jewelewicz,et al. Alternate regimens for ovulation induction in polycystic ovarian disease. , 1990, Fertility and sterility.
[6] T. Tanbo,et al. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. , 1990 .
[7] D. Ayalon,et al. IVF-ET in women with refractory polycystic ovarian disease. , 1989, European journal of obstetrics, gynecology, and reproductive biology.
[8] J. Antoine,et al. Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization. , 1988, Human reproduction.
[9] J. Antoine,et al. Results of IVF in the treatment of polycystic ovary disease. , 1988, Human reproduction.
[10] W. Dmowski,et al. Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment. , 1988, Fertility and sterility.
[11] R. Edwards,et al. EFFECT OF HIGH TONIC LEVELS OF LUTEINISING HORMONE ON OUTCOME OF IN-VITRO FERTILISATION , 1986, The Lancet.
[12] G. Mccune,et al. Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins , 1985, British journal of obstetrics and gynaecology.
[13] R. García-Flores,et al. Progressive dosages of clomiphene in hypothalamic anovulation. , 1984, Fertility and sterility.
[14] J. Halme,et al. Factors Affecting the Pregnancy Rate in Clomiphene Citrate Induction of Ovulation , 1983, Obstetrics and gynecology.
[15] V. Davajan,et al. An extended regimen of clomiphene citrate in women unresponsive to standard therapy. , 1982, Fertility and sterility.
[16] D. Mishell,et al. Clinical and laboratory predictors of clomiphene response. , 1982, Fertility and sterility.
[17] M. Shepard,et al. Relationship of weight to successful induction of ovulation with clomiphene citrate. , 1979, Fertility and sterility.
[18] M. J. Berger,et al. Clinical Aspects of the Polycystic Ovary Syndrome , 1977, Obstetrics and gynecology.
[19] D. Mishell,et al. An individualized graduated therapeutic regimen for clomiphene citrate. , 1974, American journal of obstetrics and gynecology.
[20] M. J. Whitelaw,et al. The significance of the high ovulation rate versus the low pregnancy rate with Clomid. A review of 203 private anovulatory patients. , 1970, American journal of obstetrics and gynecology.